Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020.


Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
09 2020
Historique:
received: 23 10 2019
revised: 16 01 2020
accepted: 23 01 2020
pubmed: 3 2 2020
medline: 13 11 2020
entrez: 3 2 2020
Statut: ppublish

Résumé

The evolution of multidisciplinary team-based care for women with placenta accreta spectrum disorder has delivered stepwise improvements in clinical outcomes. Central to this overall goal is the ability to limit blood loss at surgery. Placement of inflatable balloons within the pelvic arteries, most commonly in the anterior divisions of the internal iliac arteries, became popular in many centers, at the expense of prolonging surgical care and with attendant risks of vascular injury. In tandem, the need to expose pelvic sidewall anatomy to safely identify the course of the ureters re-popularized the alternative strategy of ligating the same anterior divisions of the internal iliac arteries. With incremental gains in surgical expertise, described in 5 steps in this review, our teams have witnessed a steady decline in surgical blood loss. Nevertheless, a subset of women has the most severe form of placenta accreta spectrum, namely placenta previa-percreta. Such women are at risk of major hemorrhage during surgery from vessels arising outside the territories of the internal iliac arteries. These additional blood supplies, mostly from the external iliac arteries, pose significant risks of major blood loss even in experienced hands. To address this risk, some centers, principally in China, have adopted an approach of routinely placing an infrarenal aortic balloon, with both impressively low rates of blood loss and an ability to conserve the uterus by resecting the placenta with the affected portion of the uterine wall. We review these literature developments in the context of safely performing elective cesarean hysterectomy for placenta previa-percreta, the most severe placenta accreta spectrum disorder.

Identifiants

pubmed: 32007492
pii: S0002-9378(20)30066-1
doi: 10.1016/j.ajog.2020.01.044
pmc: PMC8725207
mid: NIHMS1760038
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-329

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD094347
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Am J Obstet Gynecol. 2018 Dec;219(6):B2-B16
pubmed: 30471891
Am J Obstet Gynecol. 2017 Jul;217(1):27-36
pubmed: 28268196
Obstet Gynecol. 2015 Nov;126(5):1022-1028
pubmed: 26444128
Eur J Trauma Emerg Surg. 2018 Aug;44(4):519-526
pubmed: 28929283
Int J Gynaecol Obstet. 2019 Jul;146(1):20-24
pubmed: 31173360
J Robot Surg. 2020 Jun;14(3):473-477
pubmed: 31463880
Prenat Diagn. 2019 Oct;39(11):976-985
pubmed: 31254464
Acta Obstet Gynecol Scand. 2007;86(2):228-34
pubmed: 17364288
Diagn Interv Imaging. 2019 Jun;100(6):319-325
pubmed: 30853416
J Trauma Acute Care Surg. 2018 May;84(5):752-757
pubmed: 29697519
Obstet Gynecol. 2015 Sep;126(3):645-653
pubmed: 26214694
Cardiovasc Intervent Radiol. 2019 Mar;42(3):365-370
pubmed: 30413916
N Engl J Med. 2019 Aug 15;381(7):e12
pubmed: 31412180
Am J Obstet Gynecol. 2005 Nov;193(5):1756-8
pubmed: 16260225
J Obstet Gynaecol Can. 2016 Nov;38(11):1024-1027
pubmed: 27969555
Placenta. 2017 Sep;57:60-70
pubmed: 28864020
Ultrasound Obstet Gynecol. 2019 Jan;53(1):101-106
pubmed: 30199114
Am J Obstet Gynecol. 2007 Dec;197(6):658.e1-5
pubmed: 18060970
Int J Gynaecol Obstet. 2012 May;117(2):191-4
pubmed: 22326782
Cardiovasc Intervent Radiol. 2016 Nov;39(11):1573-1579
pubmed: 27439624
J Matern Fetal Neonatal Med. 2019 Oct;32(20):3386-3392
pubmed: 29635951
Curr Probl Diagn Radiol. 2018 Nov;47(6):445-451
pubmed: 29224889
Eur Radiol. 2018 Dec;28(12):4959-4967
pubmed: 29872910
Am J Obstet Gynecol. 2017 Aug;217(2):222.e1-222.e3
pubmed: 28487113
Acta Obstet Gynecol Scand. 2004 Aug;83(8):738-44
pubmed: 15255846
BMC Pregnancy Childbirth. 2019 Jan 15;19(1):30
pubmed: 30646863
Am J Obstet Gynecol. 2007 Oct;197(4):402.e1-5
pubmed: 17904978
Am J Obstet Gynecol. 2019 Jun;220(6):511-526
pubmed: 30849356
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:36-41
pubmed: 24965977
Acta Obstet Gynecol Scand. 2013 Apr;92(4):372-7
pubmed: 23323568
BJOG. 2017 Jan;124(1):88-95
pubmed: 27346286
Am J Obstet Gynecol. 2018 Apr;218(4):443.e1-443.e8
pubmed: 29353034
J Trauma Acute Care Surg. 2018 Feb;84(2):403-405
pubmed: 28715362
BJOG. 2019 Jan;126(1):e1-e48
pubmed: 30260097
Am J Obstet Gynecol. 2017 Jun;216(6):612.e1-612.e5
pubmed: 28213059
AJP Rep. 2018 Apr;8(2):e57-e63
pubmed: 29651358
Am J Obstet Gynecol. 1967 Jun 1;98(3):303-11
pubmed: 5621448
Am J Obstet Gynecol. 2018 Aug;219(2):193.e1-193.e9
pubmed: 29733839
Acta Obstet Gynecol Scand. 2013 Apr;92(4):386-91
pubmed: 22574880
J Obstet Gynaecol Can. 2019 Jul;41(7):1035-1049
pubmed: 31227057
J Obstet Gynaecol Res. 2009 Apr;35(2):359-63
pubmed: 19335801
J Obstet Gynaecol Res. 2008 Jun;34(3):402-4
pubmed: 18588614

Auteurs

John C Kingdom (JC)

Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada. Electronic address: john.kingdom@sinaihealthsystem.ca.

Sebastian R Hobson (SR)

Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Ally Murji (A)

Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Lisa Allen (L)

Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Rory C Windrim (RC)

Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.

Evelyn Lockhart (E)

Department of Pathology, University of New Mexico Health Science Center, Albuquerque, NM.

Sally L Collins (SL)

Department of Obstetrics & Gynaecology, University of Oxford NHS Foundation Trust, England, United Kingdom.

Hooman Soleymani Majd (H)

Department of Obstetrics & Gynaecology, University of Oxford NHS Foundation Trust, England, United Kingdom.

Moiad Alazzam (M)

Department of Obstetrics & Gynaecology, University of Oxford NHS Foundation Trust, England, United Kingdom.

Feras Naaisa (F)

Department of Gynaecology, South Bristol NHS Trust, Bristol, England, United Kingdom.

Alireza A Shamshirsaz (AA)

Maternal-Fetal Medicine Division, Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX.

Michael A Belfort (MA)

Maternal-Fetal Medicine Division, Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX.

Karin A Fox (KA)

Maternal-Fetal Medicine Division, Department of Obstetrics & Gynecology, Baylor College of Medicine, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH